Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia
Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Jim Mintz(The University of Texas at San Antonio Health Science Center), Larry Alphs(Pfizer (United States)), Robert Morlock, Scott Lancaster(Janssen (Belgium))
Cited by 55
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325
The Expert Consensus Guideline Series
|The Journal of Clinical Psychiatry|2009|281